Dhani Services limited (DSL) (formerly Indiabulls Ventures Limited), as an incorporated legal entity, came into existence on June 9, 1995, under the Companies Act, 1956. The name of the Company has been changed from 'Indiabulls Ventures Limited' to ‘Dhani Services Limited’ with effect from October 6, 2020 to align its business of providing technology enabled subscription based healthcare and transaction finance services, through its Dhani App.

The company is a technology business that operates through its app ‘Dhani’ and provides digital healthcare and transaction finance to its customers. For transaction finance, the company issue cards (virtual and physical) which come with embedded credit providing customers with daily transaction power (its customers don’t own a credit card).

DSL’s key subsidiaries include Dhani Loans and Services Limited (formerly Indiabulls Consumer Finance Limited), Indiabulls Asset Reconstruction Company Limited, Dhani Stocks Ltd ( earlier name was Indiabulls Securities), Indiabulls Investment Advisors Limited, Auxesia Soft Solutions Limited, Indiabulls Distribution Services Limited, Pushpanjli Finsolutions Limited, Devata Tradelink Limited, Arbutus Constructions Limited, Gyansagar Buildtech Limited, Savren Medicare Limited (formerly Savren Buildwell Limited), Dhani Healthcare Limited (formerly Pushpanjli Fincon Limited), Indiabulls Alternate Investments Limited, Indiabulls Infra Resources Limited, Indiabulls Consumer Products Limited, Transerv Limited, Dhani Health Middle East FZ LLC (Foreign company), Dhani Limited (Foreign company) and Dhani Ltd (Foreign company).

Business area of the company

The company provides customers with primary healthcare access over instant video calls with doctors. Customers can get access to primary medical care 24x7 on the app within 15 seconds. Doctor consultations and prescriptions are supplemented with unbranded medicines delivery at 50% discount. E-pharmacy provides customers with branded medicines at 25% discount, delivered to their doorsteps.

Market Cap	6,953 Cr	ROE	20.3%
P/E Ratio(TTM)	12.0	EPS(TTM)	0.0
P/B Ratio	2.1	Dividend Yield	0.0%
Industry P/E	21.3	Book Value	191.4
		Face Value	10.0

Fundamentals